Literature DB >> 29372084

Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study.

Mojtaba Mirzaei1, Mahboobehsadat Mirzadeh2, Mohsen Mirzaei3.   

Abstract

OBJECTIVES: Prostate cancer is a leading cause of cancer-related deaths. The number of deaths and years of life lost (YLL) due to a disease can be used to monitor health status, assess healthcare needs and determine the prioritisation and allocation of health resources within a population; in addition, the latter calculation can serve as a baseline indicator of premature mortality. This study aimed to measure prostate cancer-related mortality and YLL in Yazd Province, Iran.
METHODS: This study included all prostate cancer-related deaths in Yazd Province reported between March 2001 and March 2010. Mortality data were obtained from a provincial death registration system which integrates data from different sources. YLL was calculated based on an individual's age at death and their life expectancy according to age group.
RESULTS: During the study period, prostate cancer was the fourth most common fatal cancer among men, resulting in 324 deaths or 10.0% of all cancer-related deaths. The crude mortality rate per 100,000 individuals increased from 4.7 in 2001 to 8.8 in 2010. Premature deaths caused 1,358.7 YLL and the YLL caused by prostate cancer deaths more than doubled from 94.7 in 2001 to 196.5 in 2010.
CONCLUSION: Due to changes in population structure, it is likely that the burden of prostate cancer will continue to increase in Yazd Province. As such, it is necessary that the national health system implements screening programmes and improves public awareness of prostate cancer-associated risk factors.

Entities:  

Keywords:  Health Status Indicators; Iran; Mortality; Prostate Cancer; Years of Potential Life Lost

Mesh:

Year:  2018        PMID: 29372084      PMCID: PMC5766298          DOI: 10.18295/squmj.2017.17.04.008

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  27 in total

1.  Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics.

Authors:  Reza Pakzad; Hosein Rafiemanesh; Mahshid Ghoncheh; Arezoo Sarmad; Hamid Salehiniya; Sayedehafagh Hosseini; Zahra Sepehri; Amin Afshari-Moghadam
Journal:  Asian Pac J Cancer Prev       Date:  2016

2.  Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.

Authors:  Michael B Cook; Philip S Rosenberg; Frances A McCarty; Manxia Wu; Jessica King; Christie Eheman; William F Anderson
Journal:  Prostate       Date:  2015-01-25       Impact factor: 4.104

3.  Future burden of prostate cancer mortality in Brazil: a population-based study.

Authors:  Javier Jerez-Roig; Dyego L B Souza; Pablo F M Medeiros; Isabelle R Barbosa; Maria P Curado; Iris C C Costa; Kenio Costa Lima
Journal:  Cad Saude Publica       Date:  2014-11       Impact factor: 1.632

Review 4.  Diet, lifestyle and risk of prostate cancer.

Authors:  Alicja Wolk
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

5.  Prostate cancer in elderly men.

Authors:  Anton Stangelberger; Matthias Waldert; Bob Djavan
Journal:  Rev Urol       Date:  2008

6.  The incidence of prostate cancer in Iran: results of a population-based cancer registry.

Authors:  Alireza Sadjadi; Mehdi Nooraie; Anahita Ghorbani; Masoomeh Alimohammadian; Mohammad-Javad Zahedi; Sodeif Darvish-Moghadam; Hafez Fakheri; Masood Babai; Shahriar Semnani; Fariborz Mansour-Ghanaei; Mohammad-Ali Mohagheghi
Journal:  Arch Iran Med       Date:  2007-10       Impact factor: 1.354

7.  Race-specific geography of prostate cancer incidence.

Authors:  Laurie M DeChello; David I Gregorio; Holly Samociuk
Journal:  Int J Health Geogr       Date:  2006-12-18       Impact factor: 3.918

8.  Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds.

Authors:  N G Burnet; S J Jefferies; R J Benson; D P Hunt; F P Treasure
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

Review 9.  Prevalence of incidental prostate cancer: A systematic review of autopsy studies.

Authors:  Katy J L Bell; Chris Del Mar; Gordon Wright; James Dickinson; Paul Glasziou
Journal:  Int J Cancer       Date:  2015-04-21       Impact factor: 7.396

10.  Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death.

Authors:  Tomás J Aragón; Daphne Y Lichtensztajn; Brian S Katcher; Randy Reiter; Mitchell H Katz
Journal:  BMC Public Health       Date:  2008-04-10       Impact factor: 3.295

View more
  2 in total

1.  HoxB13 mediates AR-V7 activity in prostate cancer.

Authors:  Héctor I Navarro; Andrew S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

2.  Years of life lost due to asthma in a population-based 10-year study in Yazd, Iran.

Authors:  Hamidreza Rahavi; Alexander S Taft; Mina Mirzaei
Journal:  Lung India       Date:  2018 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.